Lone Pine Capital

Lone Pine Capital is a research-driven fundamental equity investment firm serving global partners. Their approach combines enduring methods, dynamic change, and purposeful collaboration. They integrate cross-sectional research, deep diligence, and diverse perspectives to identify high-conviction ideas aiming for outsized outcomes for their investors. Their investment philosophy emphasizes comprehensive research, both qualitative and quantitative, encompassing macro and micro perspectives, long and short positions, and public and private markets. This research method integrates various factors into a feedback loop of learning, innovation, and optimization, fueling continuous pursuit of compelling risk-reward opportunities worldwide that meet their rigorous investment criteria. They prioritize long-lasting relationships with clients to achieve mutual growth, remaining rooted in people, performance, and service, leveraging deep expertise, innovation, and enduring partnerships.
Longevity Science Foundation

Advancing scientific breakthroughs to extend human lifespan and healthspan through funding of research projects and academic collaborations.
Longwall Venture Partners

Longwall Ventures invests in highly theoretical, pre-market-fit deep tech startups that require patient capital and technical fluency to scale from prototype to global business. They focus on complex challenges in advanced manufacturing, life sciences, defence, and clean energy, providing hands-on, collaborative support to build enduring businesses.
Longwall Ventures

Longwall Ventures backs patient capital-intensive deep tech ventures where great science requires time and technical fluency to reach market readiness. They specialize in sectors like life sciences, physical sciences, advanced manufacturing, defence, and clean energy, focusing on complex challenges that demand long-term, hands-on investment and collaboration.
Lugus Capital
Lugus Capital is an Irish-based real estate investment platform offering strategic insights, data-driven analysis, and innovative thinking to deliver exceptional returns and enhance the built environment.
Lumaux
Lumaux is an Eindhoven-based seed fund that invests in Dutch deep technology companies.
Luminous Ventures

Investing in early-stage companies leveraging cutting-edge science and technology to address global challenges, particularly in healthcare and life sciences.
Lumira Ventures

Lumira Ventures invests in groundbreaking healthcare solutions across North America, focusing on life sciences innovations that address unmet medical needs, particularly in biotech, biotherapeutics, and medical devices.
Lumière AI Ventures
Lumiere provides AI-powered video intelligence and audience insights to help brands, creators, and platforms measure engagement, analyze content performance, and optimize interactive experiences through deep content analytics.
Lundbeckfond Invest

Invests in high-quality companies with strong leadership, high profitability, good cash flow, healthy balance sheets, and a persistent competitive edge to enable long-term growth in earnings and value creation. Focuses on diversification across sectors and asset classes to reduce risk. Approximately 33% of assets are managed externally, with partnerships for specific investments (e.g., property).
Lundbeckfonden BioCapital

SNIPR Biome leverages CRISPR-Cas technology to develop microbial medicines for precision killing of bacteria and gene modification, addressing critical infectious diseases like antibiotic-resistant infections in cystic fibrosis and hematologic cancers. The company focuses on selective, ultra-rapid bacterial eradication while preserving the patient’s microbiome, with a pipeline targeting pathogens of high importance, including Pseudomonas aeruginosa and antibiotic-resistant bacteria.
Luno

Luno focuses on building Future-Grade Finance™ by enabling regulated access to cryptocurrencies, tokenized stocks, and global payments infrastructure. Their platform supports embedded crypto solutions for banks and telcos, fractional ownership of assets, and cross-border stablecoin transactions.
Lux Media Investments

Lux Media Investments focuses on media and technology investments that combine principal protection with high-growth opportunities. The firm targets scalable, disruptive enterprises with scalable business models, aiming to deliver both social impact and sustainable financial returns. Investments prioritize companies with global potential, led by visionary leaders, and are structured to balance stability (via fixed-income) with transformative growth potential.
Lynx Financial (HK) Limited

Lynx Financial connects life science innovators across China, the U.S., and Europe with capital and strategic partners, leveraging a team of physicians, scientists, and investors to accelerate medical technologies to patients globally.
M Ventures (Merck)

Invests in visionary companies that develop transformative solutions in healthcare drug development, life science tools, electronics, and sustainability, with a dual strategic and financial focus. Supports entrepreneurs with active involvement in portfolio companies to drive commercial success.
M-Venture
Provides hands-on guidance for startups and businesses across the entire lifecycle—from ideation and execution (Start/Build) to crisis management (Fix) and maximizing exit value (Sell). Focuses on strategic planning, execution, and operational resilience, leveraging Howard Thaw’s 25+ years of entrepreneurial, medical, and tech industry experience.
M1 Capital
M1 Capital specializes in structuring and executing transactions for commodity traders, producers, and infrastructure owners, focusing on working capital facilities, trade finance, and M&A in mining, energy, petrochemicals, and soft commodities. Their expertise spans cross-border deals, asset-backed financing, and deal lifecycle management in complex international environments.
M12 Microsoft’s Venture Fund
M12 is Microsoft’s venture capital fund. It invests in companies from seed through Series B, including enterprise software and foundational technology.
M1720
M1720 is a venture fund that backs US technology companies at seed and Series A.
M2care

M2CARE is a venture studio investing in, operating, and developing healthtech innovations to address critical health challenges. They test feasibility, create startups from innovations, provide capital, operational support, and accelerate market access for projects.
MAIF Impact
MAIF Impact invests in innovative businesses whose models generate positive social, societal, or environmental outcomes.
MBG H Mittelständische Beteiligungsgesellschaft Hessen

MBG Hessen provides equity and mezzanine financing to small businesses and founders in Hessen, including support for investment and growth.
MBG Mittelständische Beteiligungsgesellschaft Baden-Württemberg

MBG Baden-Württemberg fördert als unabhängiger, bankenunabhängiger Finanzierungspartner innovative Start-ups, Wachstumsunternehmen und Unternehmensnachfolgen in Baden-Württemberg. Durch stille und offene Beteiligungen sowie Mezzanine-Kapital unterstützt die MBG langfristige Finanzierungslösungen, die Unternehmen handlungsfähig halten und Krisenresilienz stärken. Die tiefe Vernetzung mit Verbänden, Kammern und Beratern beschleunigt das Wachstum der Portfoliounternehmen durch Zugang zu Expertise und Netzwerkressourcen.
MBG Mittelständische Beteiligungsgesellschaft Schleswig-Holstein mbH

MBG Schleswig-Holstein provides participation and mezzanine financing for startups and small and medium-sized businesses in Schleswig-Holstein.